Prevalence of disease-modifying drug treatment gaps in patients with multiple sclerosis

被引：0
|
作者：
Joyeux, A.
Kozma, C.
Meletiche, D.
Dickson, M.
Bennett, R.
机构：
[1] Merck Serono, Geneva, Switzerland
[2] Univ S Carolina, Columbia, SC 29208 USA
[3] EMD Serono Inc, Rockland, ME USA
来源：
JOURNAL OF NEUROLOGY | 2009年 / 256卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S163 / S163
页数：1
相关论文
共 50 条
  • [41] Immunoglobulin deficiency in multiple sclerosis - prevalence and association with disease-modifying therapy and disease course
    Zoehner, G.
    Miclea, A.
    Salmen, A.
    Kamber, N.
    Diem, L.
    Friedli, C.
    Bagnoud, M.
    Ahmadi, F.
    Briner, M.
    Sedille-Mostafaie, N.
    Constantinos, K.
    Leonidas, S.
    Chan, A.
    Hoepner, R.
    Evangelopoulos, M. E.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 341 - 341
  • [42] USING A PANEL SURVEY TO IDENTIFY PREDICTORS OF DISEASE-MODIFYING DRUG ADHERENCE IN PATIENTS WITH MULTIPLE SCLEROSIS
    Phillips, A. L.
    Kozma, C. M.
    Locklear, J. C.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A400 - A400
  • [43] Estimating long-term effects of disease-modifying drug, therapy in multiple sclerosis patients
    Rudick, RA
    Cutter, GR
    Baier, M
    Weinstock-Guttman, B
    Mass, MK
    Fisher, E
    Miller, DM
    Sandrock, AW
    [J]. MULTIPLE SCLEROSIS, 2005, 11 (06): : 626 - 634
  • [44] Cost of disease-modifying therapies for multiple sclerosis
    Brown, Murray G.
    [J]. NEUROLOGY, 2015, 84 (21) : E181 - E185
  • [45] Emerging multiple sclerosis disease-modifying therapies
    Giacomini, Paul S.
    Darlington, Peter J.
    Bar-Or, Amit
    [J]. CURRENT OPINION IN NEUROLOGY, 2009, 22 (03) : 226 - 232
  • [46] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Perumal, Jai
    Khan, Omar
    [J]. CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (03) : 256 - 263
  • [47] DISEASE-MODIFYING THERAPIES FOR MULTIPLE-SCLEROSIS
    CARTER, JL
    [J]. CNS DRUGS, 1995, 3 (02) : 99 - 114
  • [48] Multiple sclerosis disease-modifying therapy and pregnancy
    Miller, Aaron E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
  • [49] Adherence to Disease-Modifying Therapies for Multiple Sclerosis
    Higuera, Lucas
    Carlin, Caroline S.
    Anderson, Sarah
    [J]. Journal of Managed Care & Specialty Pharmacy, 2016, 22 (12): : 1394 - 1401
  • [50] Emerging Disease-Modifying Therapies in Multiple Sclerosis
    Jai Perumal
    Omar Khan
    [J]. Current Treatment Options in Neurology, 2012, 14 : 256 - 263
12345